News and Updates for Healthcare Professionals

Panelists review ADA criteria for defining ‘remission’ in type 2 diabetes

In 2021, an international expert group convened by the ADA published a consensus report on the clinical definition of “remission” in type 2 diabetes.
[ Read full article ]

Cardiovascular-related deaths in the U.S. fall, but disparities remain

Findings support personalized public health interventions to help close gaps.

[ Read full article ]

HF ‘most expensive’ comorbidity, exceeding $22 billion per year

An additional $22.3 billion is spent nationally on HF-related medical services each year, with the total annual expenditure for adults with HF approaching $180 billion, according to an analysis of Medical Expenditure Panel Survey data.

[ Read full article ]

The U.S. Preventive Services Task Force

The U.S. Preventive Services Task Force is an independent, volunteer panel of national experts in disease prevention and evidence-based medicine. The Task Force works to improve the health of people nationwide by making evidence-based recommendations about clinical preventive services.

[ Visit U.S. Preventive Services Task Force website ]

NIH-supported study links poor sleep to increased risk of COPD flare-ups

Study is one of the largest to look at the links between sleep quality and COPD flare-ups.

[ Read full article ]

Prediabetes and Diabetes Screening Eligibility and Detection in US Adults After Changes to US Preventive Services Task Force and American Diabetes Association Recommendations

Prediabetes and type 2 diabetes have reached epidemic levels and are associated with major morbidity and mortality. The US Preventive Services Task Force (USPSTF) and the American Diabetes Association (ADA) recently recommended lowering the starting age for diabetes screening to 35 years to facilitate earlier detection and treatment.1,2 We estimated the proportion of asymptomatic US adults eligible for screening based on new vs current USPSTF and ADA screening guidelines, overall and among those with prediabetes or undiagnosed diabetes.

[ Read full article ]

2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association


[ Read full article ]

Chronic Obstructive Pulmonary Disease: Screening

Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.

[ Read full article ]

Aspirin Use to Prevent Cardiovascular Disease. US Preventive Services Task Force Recommendation Statement

Cardiovascular disease (CVD) is the leading cause of mortality in the US, accounting for more than 1 in 4 deaths.

[ Read full article ]

Lowering BP According to Newest Guidance Would Cut CV Events

Using the 2021 Kidney Disease: Improving Global Outcomes (KDIGO) guideline target of systolic blood pressure (BP) < 120 mm Hg, 66% of adults with chronic kidney disease (CKD) would be eligible for BP lowering, according to a study from South Korea.

[ Read full article ]